We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

22 hedge funds and large institutions have $43.7M invested in Tonix Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

22% more funds holding

Funds holding: 18 → 22 (+4)

0% more ownership

Funds ownership: 0% → 0% (+0%)

15% less capital invested

Capital invested by funds: $51.2M → $43.7M (-$7.5M)

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.04M
2
Prudential Financial
Prudential Financial
New Jersey
+$3.18M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.54M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.91M
5
BlackRock
BlackRock
New York
+$1.59M

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$325K
2
Citadel Advisors
Citadel Advisors
Florida
-$318K
3
Deutsche Bank
Deutsche Bank
Germany
-$318K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$318K
5
VF
Virtu Financial
New York
-$318K
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
51
Squarepoint
New York
$12K – – –
RJFSA
52
Raymond James Financial Services Advisors
Florida
$11K – – –
TRCT
53
Tower Research Capital (TRC)
New York
$10K – – –
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$10K – – –
AIP
55
Ameritas Investment Partners
Nebraska
$9K – – –
X
56
Xponance
Pennsylvania
$8K – – –
CCB
57
Cutter & Co Brokerage
Missouri
$7K – – –
EH
58
Equitable Holdings
New York
$7K – – –
Mackenzie Financial
59
Mackenzie Financial
Ontario, Canada
$7K – – –
MSR
60
Main Street Research
Connecticut
$7K – – –
MA
61
MONECO Advisors
Connecticut
$7K – – –
SGI
62
Summit Global Investments
Utah
$7K – – –
VHAM
63
Van Hulzen Asset Management
California
$7K – – –
BCM
64
Bridgeway Capital Management
Texas
$5K – – –
PA
65
Profund Advisors
Maryland
$5K – – –
PWM
66
Purus Wealth Management
California
$5K – – –
JSW
67
Journey Strategic Wealth
New Jersey
$4K – – –
SAF
68
Smith Anglin Financial
Texas
$4K – – –
ZIG
69
Zuckerman Investment Group
Illinois
$4K – – –
CSS
70
Cubist Systematic Strategies
Connecticut
$3K – – –
SWM
71
Spire Wealth Management
Virginia
$2K – – –
FDCDDQ
72
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.79K – – –
BHWM
73
Beaird Harris Wealth Management
Texas
$1K – – –
CA
74
CoreCap Advisors
Michigan
$1K – – –
GI
75
Gradient Investments
Minnesota
$1K – – –
1 2
3
4

TNXP Hedge Fund Activity: Q4 2021 in Review

22 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2021, worth a combined $43.7M — down 15% from $51.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TNXP positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $6.04M. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $325K sold.

  • 22 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2021, up from 18 in Q3 2021.
  • Funds reported $43.7M of Tonix Pharmaceuticals stock for Q4 2021, down 15% quarter-over-quarter.
  • 8 funds opened new Tonix Pharmaceuticals positions in Q4 2021 and 4 closed out, a net change of +4 holders.
  • The largest Tonix Pharmaceuticals buyer in Q4 2021 was D.E. Shaw & Co, an estimated $6.04M added.
  • The largest Tonix Pharmaceuticals seller in Q4 2021 was Qube Research & Technologies (QRT), an estimated $325K sold.

Based on aggregated 13F filings for Q4 2021.